260 related articles for article (PubMed ID: 36313783)
21. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration.
Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K
Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086
[TBL] [Abstract][Full Text] [Related]
23. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma.
Li Q; Huang X; Zhao Y
Cancer Biother Radiopharm; 2023 Oct; ():. PubMed ID: 37889617
[No Abstract] [Full Text] [Related]
24. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
25. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
Zhang Y; Liu K; Wang J
Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma.
Mao X; Song F; Jin J; Zou B; Dai P; Sun M; Xu W; Wang L; Kang Y
Front Immunol; 2023; 14():1202725. PubMed ID: 37465666
[TBL] [Abstract][Full Text] [Related]
27. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
[TBL] [Abstract][Full Text] [Related]
28. New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival.
Gong L; Sun X; Jia M
Sci Rep; 2023 Oct; 13(1):18271. PubMed ID: 37880378
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
[TBL] [Abstract][Full Text] [Related]
30. Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma.
Yang J; Zhang A; Luo H; Ma C
Sci Rep; 2022 Jan; 12(1):1279. PubMed ID: 35075228
[TBL] [Abstract][Full Text] [Related]
31. A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma.
Wang F; Yang K; Pan R; Xiang Y; Xiong Z; Li P; Li K; Sun H
Front Med (Lausanne); 2023; 10():1115759. PubMed ID: 37293295
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
34. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
Liao Y; Liu Q; Xiao C; Zhou J
J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel immune-related genes prognostic signature for osteosarcoma.
Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
[TBL] [Abstract][Full Text] [Related]
36. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
37. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients.
Hua L; Lei P; Hu Y
Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259
[TBL] [Abstract][Full Text] [Related]
39. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
[TBL] [Abstract][Full Text] [Related]
40. A tumor microenvironment-based prognostic index for osteosarcoma.
Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
